Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

68.86 1.84 +2.75%
Market cap
$33.1B
P/E
0.0×
Fwd P/E
24.8×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
202,938.00 198,101.00 194,777.00 185,857.00

+8 more TTM periods

Cost of Revenue
187,061.00 183,878.00 180,910.00 170,737.00
Gross Profit
15,877.00 14,223.00 13,867.00 15,120.00
SG&A Expenses
13,015.00 12,948.00 12,904.00 12,765.00
Operating Income
(5,640.00) (7,296.00) (7,623.00) (5,703.00)
Non-operating Income/Expense
1,008.00 921.00 895.00 865.00
Non-operating Interest Expenses
655.00 672.00 678.00 682.00
EBT
(4,632.00) (6,375.00) (6,728.00) (4,838.00)
Income Tax Provision
474.00 77.00 (51.00) 459.00
Income after Tax
(5,106.00) (6,452.00) (6,677.00) (5,297.00)
Non-Controlling Interest
(6.00) (8.00) (3.00) (7.00)
Net Income Common
(5,100.00) (6,444.00) (6,674.00) (5,290.00)
EPS (Basic)
(10.40) (13.12) (13.61) (10.80)
EPS (Diluted)
(10.44) (13.14) (13.62) (10.82)
Shares (Basic, Weighted)
492.54 492.47 493.50 500.67
Shares (Diluted, Weighted)
494.37 493.35 494.00 501.65
Gross Margin
7.82% 7.18% 7.12% 8.14%
EBIT Margin
(2.78%) (3.68%) (3.91%) (3.07%)
EBT margin
(2.28%) (3.22%) (3.45%) (2.60%)
Net Profit Margin
(2.51%) (3.25%) (3.43%) (2.85%)
Free Cash Flow Margin
4.41% 3.59% 2.22% 1.81%
EBITDA
(4,394.00) (6,035.00) (6,348.00) (4,443.00)
EBIT
(5,640.00) (7,296.00) (7,623.00) (5,703.00)
EPS (Diluted, from Cont. Ops)
(10.36) (13.07) (13.54) (10.77)
EPS (Diluted, Consolidated)
(10.36) (13.07) (13.54) (10.77)
EPS (Basic, Consolidated)
(10.33) (13.06) (13.54) (10.76)
Shares (Diluted, Average)
493.98 492.95 493.60 496.21
EPS (Basic, from Continuous Ops)
(10.33) (13.06) (13.54) (10.76)
Income from Continuous Operations
(5,106.00) (6,452.00) (6,677.00) (5,297.00)
Consolidated Net Income/Loss
(5,106.00) (6,452.00) (6,677.00) (5,297.00)
EBITDA Margin
(2.17%) (3.05%) (3.26%) (2.39%)
Operating Cash Flow Margin
4.80% 4.01% 2.61% 2.19%

Fold the line items

In millions of $ except per-share values · columns are period end dates